Identifies relapse predictors based on dural thickness in idiopathic hypertrophic pachymeningitis, suggesting potential for better management.
Objective Idiopathic hypertrophic pachymeningitis (IHP) is an inflammatory disease of the dura mater of an unknown underlying cause. Although corticosteroids are commonly used as a first-line treatment, mixed responses have been observed. Furthermore, biomarkers for predicting relapse independent of various symptoms and lesion morphology have not yet been identified. We aimed to identify the prognostic factors of relapse in the first episode of IHP by objectively measuring the thickness of hypertrophic lesions of the dura mater.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: